Understanding how HIV-1 packages its genetic material
RNA binding and packaging by retroviral Gag proteins
This study is looking at how the HIV-1 virus puts together its genetic material to make new copies of itself, focusing on how certain parts of the virus interact with its RNA, which is important for its growth and spread.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10796838 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which HIV-1, the virus responsible for AIDS, packages its genetic material into new viral particles. It focuses on the interactions between the HIV-1 Gag protein and specific RNA elements that are crucial for the virus's ability to replicate. By examining the differences in RNA sequences, particularly the number of guanine residues, the study aims to uncover how these variations affect the virus's ability to produce infectious particles. The research employs advanced molecular biology techniques to analyze RNA structures and their roles in viral assembly.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV-1 who are seeking new treatment options or those who are at risk of HIV infection.
Not a fit: Patients who are not infected with HIV or those who have already developed resistance to existing antiviral therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that inhibit HIV-1 packaging and assembly, potentially improving treatment options for patients with HIV.
How similar studies have performed: Previous research has shown promise in targeting viral assembly mechanisms, suggesting that this approach could lead to significant advancements in HIV treatment.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Musier-Forsyth, Karin M — Ohio State University
- Study coordinator: Musier-Forsyth, Karin M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.